Welcome to our dedicated page for John Bean Technologies Corporation news (Ticker: $JBT), a resource for investors and traders seeking the latest updates and insights on John Bean Technologies Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect John Bean Technologies Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of John Bean Technologies Corporation's position in the market.
JBT reported first quarter 2024 results with revenue of $392 million, a 1% increase. Adjusted EPS increased by 39%. The company executed a transaction agreement with Marel hf., expecting annual cost synergies of over $125 million within three years. JBT plans to close the transaction with Marel by the end of 2024. Full year guidance includes solid revenue growth and margin expansion.
